About the Company
We do not have any company description for Taysha Gene Therapies, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Taysha Gene Therapies, Inc.
Is Taysha Gene Therapies, Inc. (NASDAQ:TSHA) the Best Gene Therapy Company?
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Taysha Gene Therapies, Inc. (NASDAQ:TSHA) is the best gene therapy company to ...
Taysha Gene Therapies Inc (TSHA) Q2 2025 Earnings Call Highlights: Regulatory Milestones and ...
Despite increased net loss, Taysha Gene Therapies Inc (TSHA) advances pivotal trials and strengthens financial position with ...
Taysha Gene Therapies, Inc. (TSHA) Reports Q2 Loss, Beats Revenue Estimates
Taysha Gene Therapies, Inc. (TSHA) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.09 per share a year ago.
Taysha Gene Therapies, Inc. (TSHA) Q4 2023 Earnings Call Transcript
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2023 Earnings Conference Call March 19, 2024 4:30 PM ETCompany ParticipantsHayleigh Collins - Director, Head of ...
Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here ...
Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results.
Trinity Capital Inc. Provides $40 Million Term Loan to Taysha Gene ...
--Trinity Capital Inc., a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $40 million in term loans to Taysha Gene Therapies, Inc ...
Taysha Gene Therapies, Inc. (TSHA) CEO RA Session II on Q1 2022 Results ...
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) Q1 2022 Earnings Conference Call May 16, 2022 8:00 AM ET Company Participants Kimberly Lee - Chief Corporate Affairs Officer RA Session II - President ...
What Is The Ownership Structure Like For Taysha Gene Therapies, Inc ...
May 12, 2021 — 06:50 am EDT Written by Simply Wall St for Simply Wall St -> The big shareholder groups in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) have power over the company.
Taysha Gene Therapies hauls in a $50 million lifeline for its gene ...
Taysha announced the investment late Monday from Tokyo-based Astellas Pharma Inc. to push forward its gene therapies for treating Rett syndrome and a disorder called giant axonal neuropathy.
Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q2 Earnings? What You Should Know
Taysha Gene Therapies, Inc. (TSHA) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus ...
Is Taysha Gene Therapies, Inc. (NASDAQ:TSHA) the Best Gene Therapy ...
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) has made progress with TSHA-102, its leading gene therapy program for Rett Syndrome. This progress includes reporting positive long-term data for the ...
Similar Companies
Loading the latest forecasts...